JPH07330697A - Production of substituted indan derivative - Google Patents

Production of substituted indan derivative

Info

Publication number
JPH07330697A
JPH07330697A JP15304394A JP15304394A JPH07330697A JP H07330697 A JPH07330697 A JP H07330697A JP 15304394 A JP15304394 A JP 15304394A JP 15304394 A JP15304394 A JP 15304394A JP H07330697 A JPH07330697 A JP H07330697A
Authority
JP
Japan
Prior art keywords
reaction
acid
compound
added
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP15304394A
Other languages
Japanese (ja)
Inventor
Hiroki Sato
浩樹 佐藤
Katsuo Shinozaki
勝雄 篠崎
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zeria Pharmaceutical Co Ltd
Original Assignee
Zeria Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeria Pharmaceutical Co Ltd filed Critical Zeria Pharmaceutical Co Ltd
Priority to JP15304394A priority Critical patent/JPH07330697A/en
Publication of JPH07330697A publication Critical patent/JPH07330697A/en
Pending legal-status Critical Current

Links

Abstract

PURPOSE:To obtain a substituted indan derivative of high purity, a synthetic intermediate for, for example, a strong thromboxane A2 antagonist by Hoffmann rearrangement reaction of a specific compound, in a high yield with industrial advantage without use of expensive reagents economically with excellent operability and safety. CONSTITUTION:A compound of formula I (m, n are each 0-3; R1 is H, a lower alkyl; R2 is H, O) is subjected to Hoffmann rearrangement reaction to give this substituted indan derivative, for example, 5-(2-aminomethyl)indanylacetic acid. In the production, the reaction of the compound of formula I is carried out in the presence of an alkali such as sodium hydroxide and a salt of oxo-acid such as sodium hypochlorite.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医薬品として有用なイ
ンダン誘導体の製造中間体である一般式(II)
FIELD OF THE INVENTION The present invention relates to an intermediate of the formula (II) which is an intermediate for the production of indane derivatives useful as a medicine.

【0002】[0002]

【化3】 [Chemical 3]

【0003】(式中、m、nはそれぞれ0〜3の数を示
し、R1は水素原子、低級アルキル基であり、R2は水素
原子、酸素原子である。)で表される置換インダン誘導
体の新規な製造法に関する。
(In the formula, m and n each represent a number of 0 to 3, R 1 is a hydrogen atom or a lower alkyl group, and R 2 is a hydrogen atom or an oxygen atom.) The present invention relates to a novel method for producing a derivative.

【0004】[0004]

【従来の技術と発明が解決しようとする課題】国際特許
公開WO92/15558号公報記載のインダン誘導体は、トロン
ボキサンA2拮抗剤として有用な医薬化合物であり、そ
の製法が当該公報において開示されている。それによれ
ば、インダン誘導体は、インダン−2−イルアルキルカ
ルボン酸を出発原料として、アシルアジドのクルチウス
転位反応を用いる方法で製造することができる。しかし
ながら、この方法では、爆発性のあるアシルアジドが中
間体として生成してくるため、工業的に用いることが困
難であった。
BACKGROUND OF THE INVENTION The indane derivative described in International Patent Publication WO92 / 15558 is a pharmaceutical compound useful as a thromboxane A 2 antagonist, and its production method is disclosed in the publication. There is. According to this, the indane derivative can be produced by a method using the Curtius rearrangement reaction of acyl azide with indan-2-ylalkylcarboxylic acid as a starting material. However, this method is difficult to use industrially because an explosive acyl azide is produced as an intermediate.

【0005】一方、特開平4−264068号公報に
は、5−アセチル−2−(アセチルアミノメチル)イン
ダンからウィルゲロット反応及びそれに続く加水分解反
応により置換インダン誘導体を製造する方法が開示され
ているが、収率が低く、工業的に満足できるものではな
かった。
On the other hand, JP-A-4-264068 discloses a method for producing a substituted indane derivative from 5-acetyl-2- (acetylaminomethyl) indane by the Wilgerlot reaction and the subsequent hydrolysis reaction. However, the yield was low and it was not industrially satisfactory.

【0006】[0006]

【課題を解決するための手段】本発明者らは、上記問題
を解決するため鋭意研究を行い、アルカリとオキソ酸の
塩を用いて、いわゆるホフマン転位反応を行うことによ
り当該公報記載のインダン誘導体の製造中間体である置
換インダン誘導体を安全かつ経済的に得ることができる
ことを見出し、本製造法を完成した。
[Means for Solving the Problems] The inventors of the present invention have conducted extensive studies in order to solve the above-mentioned problems, and by using a salt of an alkali and an oxo acid, a so-called Hoffman rearrangement reaction is carried out, whereby the indane derivative described in the publication It was found that the substituted indane derivative, which is a production intermediate of, can be obtained safely and economically, and the present production method was completed.

【0007】即ち、本発明は一般式(I)That is, the present invention has the general formula (I)

【0008】[0008]

【化4】 [Chemical 4]

【0009】(式中、m、n、R1、R2は前記と同意義
である。)で表される化合物にホフマン転位反応を行う
ことを特徴とする、一般式(II)
(Wherein m, n, R 1 and R 2 have the same meanings as defined above), a Hoffman rearrangement reaction is carried out on the compound represented by the general formula (II).

【0010】[0010]

【化5】 [Chemical 5]

【0011】(式中、m、n、R1、R2は前記と同意義
である。)で表される置換インダン誘導体の製造法に関
する。
The present invention relates to a process for producing a substituted indane derivative represented by the formula (m, n, R 1 and R 2 are as defined above).

【0012】本発明において、R2が酸素原子である場
合、この酸素原子は隣接炭素原子と共にカルボニル基を
形成する。なお、上記「低級アルキル基」とは、炭素数
1〜4のアルキル基を示し、例えばメチル基、エチル
基、n−プロピル基、イソプロピル基、n−ブチル基、
イソブチル基、sec−ブチル基、tert−ブチル基
が挙げられる。
In the present invention, when R 2 is an oxygen atom, this oxygen atom forms a carbonyl group with an adjacent carbon atom. The "lower alkyl group" refers to an alkyl group having 1 to 4 carbon atoms, such as a methyl group, an ethyl group, an n-propyl group, an isopropyl group, an n-butyl group,
Examples thereof include an isobutyl group, sec-butyl group and tert-butyl group.

【0013】本発明の製造法に用いる一般式(I)の化
合物は、適宜公知の方法を組み合わせることによって製
造することができ、例えば次に示す参考製造法をあげる
ことができる。
The compound of the general formula (I) used in the production method of the present invention can be produced by appropriately combining known methods. For example, the following reference production method can be mentioned.

【0014】参考製造法1Reference Manufacturing Method 1

【0015】[0015]

【化6】 [Chemical 6]

【0016】(式中、R1は前記と同意義、R1’は低級
アルキル基、Xはハロゲン原子である。) 2−インダニル酢酸(III)を常法により塩化チオニ
ル、三臭化リンなどのハロゲン化剤により酸ハロゲン化
物(IV)とした後、アンモニア水と反応させて2−イン
ダニルアセトアミド(V)を製造する。次に塩化アルミ
ニウム、四塩化チタン、四塩化スズなどのルイス酸の存
在下に2−インダニルアセトアミド(V)とα−ハロ−
α−メチルチオ酢酸アルキルエステルを縮合(フリーデ
ルクラフツ反応)させ化合物(VI)とし、続いて酢酸中
で亜鉛により還元して、一般式(I)中のm及びnが0
かつR2が水素原子である化合物(Ia)を製造するこ
とができる。なお、化合物(Ia)中R1が低級アルキ
ル基の場合は、加水分解反応によって水素原子とするこ
とができる。
(In the formula, R 1 has the same meaning as described above, R 1 'is a lower alkyl group, and X is a halogen atom.) 2-Indanyl acetic acid (III) is thionyl chloride, phosphorus tribromide, etc. by a conventional method. After being converted into an acid halide (IV) by the halogenating agent of 1), it is reacted with aqueous ammonia to produce 2-indanylacetamide (V). Then, in the presence of a Lewis acid such as aluminum chloride, titanium tetrachloride or tin tetrachloride, 2-indanylacetamide (V) and α-halo-
α-Methylthioacetic acid alkyl ester is condensed (Friedel-Crafts reaction) to give compound (VI), which is subsequently reduced with zinc in acetic acid so that m and n in the general formula (I) are 0.
A compound (Ia) in which R 2 is a hydrogen atom can be produced. When R 1 in the compound (Ia) is a lower alkyl group, it can be converted into a hydrogen atom by a hydrolysis reaction.

【0017】参考製造法2Reference Manufacturing Method 2

【0018】[0018]

【化7】 [Chemical 7]

【0019】(式中、R1、R1’、Xは前記と同意義で
ある。) 2−インダニル酢酸(III)とα−ハロ−α−メチルチ
オ酢酸アルキルエステルを参考製造法1に準じてフリー
デルクラフツ反応により縮合し、化合物(VII)を製造
する。続いて化合物(VII)は酢酸中で亜鉛により還元
して化合物(VIII)とし、ハロゲン化剤により酸ハロゲ
ン化物(IX)とした後、アンモニア水を反応させること
により化合物(Ia)を製造することができる。
(In the formula, R 1 , R 1 'and X have the same meanings as described above.) 2-indanyl acetic acid (III) and α-halo-α-methylthioacetic acid alkyl ester were prepared according to Reference Production Method 1. The compound (VII) is produced by condensation by Friedel-Crafts reaction. Then, the compound (VII) is reduced with zinc in acetic acid to give a compound (VIII), which is converted into an acid halide (IX) with a halogenating agent, and then reacted with aqueous ammonia to produce a compound (Ia). You can

【0020】参考製造法3Reference manufacturing method 3

【0021】[0021]

【化8】 [Chemical 8]

【0022】(式中、R1、R1’、Xは前記と同意義で
ある。) 参考製造例1と同様に製造した2−インダニルアセトア
ミド(V)とクロログリオキシル酸メチルエステル、ク
ロログリオキシル酸エチルエステルなどのシュウ酸エス
テル・酸ハロゲン化物をフリーデルクラフツ反応により
縮合し、一般式(I)中のm及びnが0かつR2が酸素
原子である化合物(Ib)を製造することができる。な
お、化合物(Ib)中R1が低級アルキル基の場合は、
加水分解反応によって水素原子とすることができる。
(In the formula, R 1 , R 1 'and X have the same meanings as described above.) 2-Indanylacetamide (V) produced in the same manner as in Reference Production Example 1, chloroglyoxylic acid methyl ester, and chloroglyoxyl A compound (Ib) wherein m and n in the general formula (I) are 0 and R 2 is an oxygen atom can be produced by condensing an oxalic acid ester / acid halide such as acid ethyl ester by Friedel-Crafts reaction. it can. When R 1 in the compound (Ib) is a lower alkyl group,
It can be converted into a hydrogen atom by a hydrolysis reaction.

【0023】上記のようにして得た一般式(I)で表さ
れる化合物は、本発明の製造法(ホフマン転位反応)に
よって置換インダン誘導体(II)へ導くことができる。
本製造法は適当な溶媒中、アルカリ及びオキソ酸の塩を
用いて実施する。化合物(I)は式中のR1が水素原子
であってもアルキル基であっても反応に用いることがで
きるが、R1がアルキル基の場合は酸やアルカリの加水
分解反応により水素原子とすることが特に好ましい。反
応に用いられる溶媒としては、水または反応に関与しな
い溶媒と水との混合溶媒が用いられる。反応に用いられ
るアルカリとしては、例えば水酸化ナトリウム、水酸化
カリウムなどの水酸化アルカリ金属があげられ、好まし
くは水酸化ナトリウムが用いられる。また、オキソ酸の
塩としては、次亜塩素酸ナトリウム、次亜塩素酸カリウ
ムなどの次亜塩素酸塩や、次亜臭素酸塩が用いられる。
さらに、オキソ酸の塩に代えて臭素を用いることも可能
である。反応温度は室温から溶媒の還流温度の範囲で反
応を行うことができる。
The compound represented by the general formula (I) obtained as described above can be converted into the substituted indane derivative (II) by the production method (Hoffmann rearrangement reaction) of the present invention.
This production method is carried out using a salt of an alkali and an oxo acid in a suitable solvent. Compound (I) can be used in the reaction regardless of whether R 1 in the formula is a hydrogen atom or an alkyl group. However, when R 1 is an alkyl group, it is converted to a hydrogen atom by a hydrolysis reaction of acid or alkali. Is particularly preferable. As the solvent used in the reaction, water or a mixed solvent of a solvent not involved in the reaction and water is used. Examples of the alkali used in the reaction include alkali metal hydroxides such as sodium hydroxide and potassium hydroxide, and sodium hydroxide is preferably used. As the salt of oxo acid, hypochlorite such as sodium hypochlorite and potassium hypochlorite, or hypobromite is used.
Furthermore, it is also possible to use bromine instead of the salt of oxo acid. The reaction temperature can be from room temperature to the reflux temperature of the solvent.

【0024】本製造法によって、置換インダン誘導体
(II)は高収率で得られ、しかも夾雑物が極めて少ない
ため、反応混合物あるいは粗結晶のままで次の反応に供
することも可能であり、工業的に有利である。
According to the present production method, the substituted indane derivative (II) can be obtained in a high yield, and since the amount of impurities is extremely small, it is possible to use it in the next reaction as a reaction mixture or crude crystal as it is. Is advantageous.

【0025】かくして得られた置換インダン誘導体(I
I)は、例えばハロゲン化ベンゼンスルホン酸誘導体な
どと縮合させることにより国際特許公開WO92/15558号公
報記載の化合物を製造することができる。本縮合反応
は、縮合剤の存在または非存在下に実施することができ
る。縮合剤としては、例えば炭酸アルカリ金属、炭酸水
素アルカリ金属、トリ低級アルキルアミン、ピリジンな
ど慣用のものをいずれも用いることができる。本反応は
適当な溶媒、例えばトルエンなどの炭化水素系溶媒を用
いて実施するのが好ましい。
The substituted indane derivative (I
For I), for example, the compound described in International Patent Publication WO92 / 15558 can be produced by condensation with a halogenated benzenesulfonic acid derivative or the like. This condensation reaction can be carried out in the presence or absence of a condensing agent. As the condensing agent, any conventional one such as alkali metal carbonate, alkali metal hydrogen carbonate, tri-lower alkylamine, pyridine can be used. This reaction is preferably carried out using a suitable solvent, for example, a hydrocarbon solvent such as toluene.

【0026】本発明に用いる化合物(I)はインダン骨
格の2位に不斉炭素原子を有し、それに基づく2種の光
学異性体が存在するが、本製造法は光学活性に影響を及
ぼさないため、化合物(I)の光学異性体に対応する置
換インダン誘導体(II)を製造することができる。
The compound (I) used in the present invention has an asymmetric carbon atom at the 2-position of the indane skeleton, and there are two optical isomers based on the asymmetric carbon atom. However, this production method does not affect the optical activity. Therefore, the substituted indane derivative (II) corresponding to the optical isomer of the compound (I) can be produced.

【0027】[0027]

【実施例】次に参考例により一般式(II)で表される化
合物の製造例を、また実施例を挙げて本発明を詳しく説
明するが、本発明はこれらによって限定されるものでは
ない。
EXAMPLES The present invention will be described in detail with reference to Production Examples of compounds represented by the general formula (II) by reference examples and Examples, but the present invention is not limited thereto.

【0028】参考例1 5−(2−カルバモイルメチル)インダニル酢酸エチル
エステルの製造
Reference Example 1 Preparation of 5- (2-carbamoylmethyl) indanyl acetic acid ethyl ester

【0029】工程1 2−インダニル酢酸10.0gに塩化チオニル7.1g
及びジメチルホルムアミド1滴を加え室温で1時間攪拌
した。反応液を濃縮し、2−インダニルアセチルクロリ
ド9.9gを黄色油状物として得た。収率99%。 NMR(CDCl3)δ:2.65(dd,2H),2.91〜3.23(m,5H),7.
12〜7.21(m,4H)
Step 1 10.0 g of 2-indanyl acetic acid and 7.1 g of thionyl chloride
And 1 drop of dimethylformamide were added, and the mixture was stirred at room temperature for 1 hour. The reaction solution was concentrated to obtain 9.9 g of 2-indanylacetyl chloride as a yellow oily substance. Yield 99%. NMR (CDCl 3 ) δ: 2.65 (dd, 2H), 2.91 to 3.23 (m, 5H), 7.
12 to 7.21 (m, 4H)

【0030】工程2 工程1で得られた2−インダニルアセチルクロリド9.
9gをテトラヒドロフラン5mlに溶解し、氷冷下で28
%アンモニア水32ml中に滴下した。析出した粗結晶を
濾取し、エタノール−水混液から再結晶して、2−イン
ダニルアセトアミド8.72gを無色結晶として得た。
収率89%。 融点:148〜150℃ NMR(CDCl3)δ:2.38(d,2H),2.65(dd,2H),2.83〜2.
99(m,1H),3.16(dd,2H),5.48(brs,1H),5.67(brs,1H),7.1
0〜7.21(m,4H)
Step 2 2-indanyl acetyl chloride obtained in Step 1.
Dissolve 9 g in 5 ml of tetrahydrofuran, and under ice cooling 28
% Ammonia water 32 ml. The precipitated crude crystals were collected by filtration and recrystallized from a mixed solution of ethanol and water to obtain 8.72 g of 2-indanylacetamide as colorless crystals.
Yield 89%. Melting point: 148-150 ° C NMR (CDCl 3 ) δ: 2.38 (d, 2H), 2.65 (dd, 2H), 2.83-2.
99 (m, 1H), 3.16 (dd, 2H), 5.48 (brs, 1H), 5.67 (brs, 1H), 7.1
0 ~ 7.21 (m, 4H)

【0031】工程3 工程2で得られた2−インダニルアセトアミド4.0g
を1,2−ジクロロエタン20mlに懸濁し、α−クロロ
−α−メチルチオ酢酸エチルエステル4.6gを加え、
氷冷下で四塩化スズ6.4mlを15分間かけて滴下し、
室温で1.5時間攪拌した。反応液を水100ml中に注
ぎ5分間攪拌した後、1,2−ジクロロエタン層を分取
し、残った水層をクロロホルムで抽出した。1,2−ジ
クロロエタン層とクロロホルム層を合し、飽和食塩水で
洗浄した後、無水硫酸マグネシウムで乾燥した。溶媒を
留去し、α−[5−(2−カルバモイルメチル)インダ
ニル]−α−メチルチオ酢酸エチルエステル6.9gを
淡黄色油状物として得た。収率99%。 NMR(CDCl3)δ:1.26(t,3H),2.09(s,3H),2.37(d,2
H),2.56〜2.71(m,2H),2.83〜3.01(m,1H),3.06〜3.22(m,
2H),4.09〜4.30(m,2H),4.46(s,1H),5.51(brs,2H),7.10
〜7.34(m,3H)
Step 3 4.0 g of 2-indanyl acetamide obtained in Step 2
Was suspended in 20 ml of 1,2-dichloroethane, and 4.6 g of α-chloro-α-methylthioacetic acid ethyl ester was added,
Under ice cooling, 6.4 ml of tin tetrachloride was added dropwise over 15 minutes,
Stir at room temperature for 1.5 hours. The reaction solution was poured into 100 ml of water and stirred for 5 minutes, the 1,2-dichloroethane layer was separated, and the remaining aqueous layer was extracted with chloroform. The 1,2-dichloroethane layer and the chloroform layer were combined, washed with saturated saline and then dried over anhydrous magnesium sulfate. The solvent was distilled off to obtain 6.9 g of α- [5- (2-carbamoylmethyl) indanyl] -α-methylthioacetic acid ethyl ester as a pale yellow oily substance. Yield 99%. NMR (CDCl 3 ) δ: 1.26 (t, 3H), 2.09 (s, 3H), 2.37 (d, 2
H), 2.56 to 2.71 (m, 2H), 2.83 to 3.01 (m, 1H), 3.06 to 3.22 (m,
2H), 4.09 ~ 4.30 (m, 2H), 4.46 (s, 1H), 5.51 (brs, 2H), 7.10
~ 7.34 (m, 3H)

【0032】工程4 工程3で得た5−(2−カルバモイルメチル)インダニ
ルメチルチオ酢酸エチルエステル6.9gを酢酸20ml
に溶解し、攪拌下亜鉛粉末6gを加えて2時間還流し
た。反応液を室温まで放冷し、吸引濾過後、残渣を酢酸
エチルで洗浄した。濾液と洗浄液を合し、減圧濃縮した
後、水50mlを加え20分間攪拌した。析出した粗結晶
を濾取し、水で洗浄した後、ヘキサンー酢酸エチル混液
から再結晶して5−(2−カルバモイルメチル)インダ
ニル酢酸エチルエステル4.91gを得た。収率83
%。
Step 4 6.9 g of 5- (2-carbamoylmethyl) indanylmethylthioacetic acid ethyl ester obtained in Step 3 was added to 20 ml of acetic acid.
Was dissolved in the mixture, 6 g of zinc powder was added with stirring, and the mixture was refluxed for 2 hours. The reaction solution was allowed to cool to room temperature, suction filtered, and the residue was washed with ethyl acetate. The filtrate and the washing solution were combined, concentrated under reduced pressure, 50 ml of water was added, and the mixture was stirred for 20 minutes. The precipitated crude crystals were collected by filtration, washed with water and then recrystallized from a mixed solution of hexane-ethyl acetate to obtain 5- (2-carbamoylmethyl) indanyl acetic acid ethyl ester (4.91 g). Yield 83
%.

【0033】参考例2 5−(2−カルバモイルメチル)インダニル酢酸の製造Reference Example 2 Preparation of 5- (2-carbamoylmethyl) indanyl acetic acid

【0034】工程1 2−インダニル酢酸100.4gにα−クロロ−α−メ
チルチオ酢酸エチルエステル95.9g及び1,2−ジ
クロロエタン300mlを加え懸濁し、5℃まで冷却し
た。この懸濁液に、1,2−ジクロロエタン50mlに溶
解した四塩化スズ82mlを、内温を15℃以下に保ちな
がら30分間かけて滴下し、室温で40分間攪拌した。
反応液を氷400gに1N塩酸600mlを加えた液に注
ぎ、5分間攪拌した。1,2−ジクロロエタン層を分取
し、残った水層をジクロロメタン200mlで抽出した。
1,2−ジクロロエタン層とジクロロメタン層を合し、
1N塩酸、飽和食塩水で順次洗浄し、無水硫酸マグネシ
ウムで乾燥した。溶媒を減圧留去し、α−[5−(2−
カルボキシメチル)インダニル]−α−メチルチオ酢酸
エチルエステル176gを黄色油状物として得た。収率
99%。 NMR(CDCl3)δ:1.27(t,3H),2.09(s,3H),2.55(d,2
H),2.54〜2.71(m,2H),2.85〜2.93(m,1H),3.11〜3.19(m,
2H),4.13〜4.27(m,2H),4.47(s,1H),7.14〜7.30(m,3H)
Step 1 To 100.4 g of 2-indanyl acetic acid, 95.9 g of α-chloro-α-methylthioacetic acid ethyl ester and 300 ml of 1,2-dichloroethane were added and suspended, and the mixture was cooled to 5 ° C. 82 ml of tin tetrachloride dissolved in 50 ml of 1,2-dichloroethane was added dropwise to this suspension over 30 minutes while keeping the internal temperature at 15 ° C or lower, and the mixture was stirred at room temperature for 40 minutes.
The reaction solution was poured into a solution obtained by adding 600 ml of 1N hydrochloric acid to 400 g of ice and stirred for 5 minutes. The 1,2-dichloroethane layer was separated and the remaining aqueous layer was extracted with 200 ml of dichloromethane.
Combine the 1,2-dichloroethane layer and the dichloromethane layer,
The extract was washed successively with 1N hydrochloric acid and saturated saline and dried over anhydrous magnesium sulfate. The solvent was distilled off under reduced pressure, and α- [5- (2-
176 g of carboxymethyl) indanyl] -α-methylthioacetic acid ethyl ester was obtained as a yellow oil. Yield 99%. NMR (CDCl 3 ) δ: 1.27 (t, 3H), 2.09 (s, 3H), 2.55 (d, 2
H), 2.54 to 2.71 (m, 2H), 2.85 to 2.93 (m, 1H), 3.11 to 3.19 (m,
2H), 4.13 to 4.27 (m, 2H), 4.47 (s, 1H), 7.14 to 7.30 (m, 3H)

【0035】工程2 工程1で得たα−[5−(2−カルボキシメチル)イン
ダニル]−α−メチルチオ酢酸エチルエステル176g
を酢酸350mlに溶解し、攪拌下で亜鉛粉末112.4
gを加えて2時間還流した。室温まで放冷後、反応液を
吸引濾過し、残渣を酢酸エチルで洗浄した。濾液と洗浄
液を合した後、溶媒を留去し、残留物を氷水1500ml
に加え30分間攪拌した。析出した結晶を濾取し、5−
(2−カルボキシメチル)インダニル酢酸エチルエステ
ル142.8gを得た。収率97%。 融点:54〜56℃ NMR(CDCl3)δ:1.25(t,3H),2.54(d,2H),2.60〜2.6
8(m,2H),2.84〜2.95(m,1H),3.10〜3.19(m,2H),3.57(s,2
H),4.14(q,2H),7.04〜7.18(m,3H)
Step 2 176 g of α- [5- (2-carboxymethyl) indanyl] -α-methylthioacetic acid ethyl ester obtained in Step 1
Was dissolved in 350 ml of acetic acid, and zinc powder 112.4 was stirred under stirring.
g and refluxed for 2 hours. After allowing to cool to room temperature, the reaction solution was suction filtered and the residue was washed with ethyl acetate. After the filtrate and the washing solution were combined, the solvent was distilled off and the residue was replaced with 1500 ml of ice water.
Was stirred for 30 minutes. The precipitated crystals were collected by filtration, and 5-
142.8 g of (2-carboxymethyl) indanyl acetic acid ethyl ester was obtained. Yield 97%. Melting point: 54-56 ° C NMR (CDCl 3 ) δ: 1.25 (t, 3H), 2.54 (d, 2H), 2.60-2.6
8 (m, 2H), 2.84 to 2.95 (m, 1H), 3.10 to 3.19 (m, 2H), 3.57 (s, 2
H), 4.14 (q, 2H), 7.04 to 7.18 (m, 3H)

【0036】工程3 工程2で得られた5−(2−カルボキシメチル)インダ
ニル酢酸エチルエステル139.8gに塩化チオニル4
6ml及びジメチルホルムアミド0.2mlを加え、室温で
2時間攪拌した。反応液にトルエン100mlを加え、溶
媒を留去し、5−[2−(クロロホルミル)メチル]イ
ンダニル酢酸エチルエステル148.8gを黄色油状物
として得た。収率99%。 MS(m/z):280,282(M+) NMR(CDCl3)δ:1.26(t,3H),2.61〜2.68(m,2H),2.9
1〜3.20(m,5H),3.57(s,2H),4.15(q,2H),7.05〜7.16(m,3
H)
Step 3 To 139.8 g of 5- (2-carboxymethyl) indanyl acetic acid ethyl ester obtained in Step 2 was added thionyl chloride 4.
6 ml and 0.2 ml of dimethylformamide were added, and the mixture was stirred at room temperature for 2 hours. Toluene (100 ml) was added to the reaction solution and the solvent was evaporated to obtain 5- [2- (chloroformyl) methyl] indanyl acetic acid ethyl ester (148.8 g) as a yellow oil. Yield 99%. MS (m / z): 280,282 (M + ) NMR (CDCl 3 ) δ: 1.26 (t, 3H), 2.61 to 2.68 (m, 2H), 2.9
1 to 3.20 (m, 5H), 3.57 (s, 2H), 4.15 (q, 2H), 7.05 to 7.16 (m, 3
H)

【0037】工程4 工程3で得た5−[2−(クロロホルミル)メチル]イ
ンダニル酢酸エチルエステル148.8gをトルエン5
0mlに溶解し、氷冷下で28%アンモニア水220mlと
水100mlの混合溶液中に、内温を15℃以下に保ちな
がら30分間かけて滴下した。析出した結晶を濾取し、
水で洗浄した後風乾し、5−(2−カルバモイルメチ
ル)インダニル酢酸エチルエステル136.5gを黄土
色結晶として得た。収率99%。 融点:109〜110℃ MS(m/z):261(M+) NMR(CDCl3)δ:1.26(t,3H),2.37(d,2H),2.58〜2.6
8(m,4H),2.87〜2.98(m,1H),3.10〜3.19(m,2H),3.57(s,2
H),4.15(q,2H),5.36(brs,2H),7.04〜7.16(m,3H)
Step 4 148.8 g of ethyl 5- [2- (chloroformyl) methyl] indanylacetic acid obtained in Step 3 was added to toluene 5
It was dissolved in 0 ml and added dropwise to a mixed solution of 220 ml of 28% ammonia water and 100 ml of water under ice cooling over 30 minutes while keeping the internal temperature at 15 ° C or lower. The precipitated crystals are collected by filtration,
After washing with water and air-drying, 136.5 g of 5- (2-carbamoylmethyl) indanyl acetic acid ethyl ester was obtained as ocher crystals. Yield 99%. Melting point: 109 to 110 ° C MS (m / z): 261 (M + ) NMR (CDCl 3 ) δ: 1.26 (t, 3H), 2.37 (d, 2H), 2.58 to 2.6
8 (m, 4H), 2.87 ~ 2.98 (m, 1H), 3.10 ~ 3.19 (m, 2H), 3.57 (s, 2
H), 4.15 (q, 2H), 5.36 (brs, 2H), 7.04 to 7.16 (m, 3H)

【0038】工程5 工程4で得られた5−(2−カルバモイルメチル)イン
ダニル酢酸エチルエステル134.0gをメタノール2
70mlに懸濁し、この懸濁液に氷冷下、96%水酸化ナ
トリウム32.0gを水270mlに溶解した水溶液を滴
下し、室温で3時間攪拌した。反応液を濃縮し、濃塩酸
を加えてpH2に調整し、析出した結晶を吸引濾取し、
水で洗浄した後風乾し、メタノール−水混液から再結晶
して5−(2−カルバモイルメチル)インダニル酢酸8
5.1gを無色結晶として得た。 収率71%。 融点:188〜191℃ MS(m/z):233(M+) NMR(DMSO-d6)δ:2.19(d,2H),2.54〜2.60(m,2H),
2.65〜2.75(m,1H),2.78〜3.01(m,2H),3.48(s,2H),6.75
(brs,1H),6.97〜7.19(m,3H),7.29(brs,1H),12.22(brs,1
H)
Step 5 134.0 g of ethyl 5- (2-carbamoylmethyl) indanylacetic acid obtained in Step 4 was added to methanol 2
An aqueous solution prepared by dissolving 32.0 g of 96% sodium hydroxide in 270 ml of water was added dropwise to this suspension under ice cooling, and the mixture was stirred at room temperature for 3 hours. The reaction solution was concentrated, concentrated hydrochloric acid was added to adjust the pH to 2, and the precipitated crystals were collected by suction filtration,
After washing with water, air-drying and recrystallizing from a methanol-water mixture to give 5- (2-carbamoylmethyl) indanyl acetic acid 8
5.1 g was obtained as colorless crystals. Yield 71%. Melting point: 188 to 191 ° C MS (m / z): 233 (M + ) NMR (DMSO-d 6 ) δ: 2.19 (d, 2H), 2.54 to 2.60 (m, 2H),
2.65 ~ 2.75 (m, 1H), 2.78 ~ 3.01 (m, 2H), 3.48 (s, 2H), 6.75
(brs, 1H), 6.97 ~ 7.19 (m, 3H), 7.29 (brs, 1H), 12.22 (brs, 1
H)

【0039】実施例1 5−(2−アミノメチル)インダニル酢酸の製造Example 1 Preparation of 5- (2-aminomethyl) indanyl acetic acid

【0040】[0040]

【化9】 [Chemical 9]

【0041】参考例2で得た5−(2−カルバモイルメ
チル)インダニル酢酸1.0gに、96%水酸化ナトリ
ウム630mgを水20mlに溶かした水溶液を加えて溶解
した。氷冷下で12%次亜塩素酸ナトリウム2.5gを
加え、同温で10分間、次いで室温で50分間攪拌し、
さらに15分間かけて内温90℃まで加熱し、内温90
℃で20分間反応させた。反応液を放冷し、塩酸を加え
てpH6.5とし、析出した結晶を濾取することで5−
(2−アミノメチル)インダニル酢酸667mgを無色結
晶として得た。収率76%。 融点:224〜226℃ MS(m/z):205(M+) NMR(CD3OD)δ:2.64〜2.76(m,3H),2.99〜3.10(m,4
H),3.45(s,2H),7.09〜7.16(m,3H)
An aqueous solution prepared by dissolving 630 mg of 96% sodium hydroxide in 20 ml of water was added to 1.0 g of 5- (2-carbamoylmethyl) indanylacetic acid obtained in Reference Example 2 and dissolved. 2.5 g of 12% sodium hypochlorite was added under ice cooling, and the mixture was stirred at the same temperature for 10 minutes and then at room temperature for 50 minutes,
Heat the inner temperature to 90 ° C over an additional 15 minutes to reach an inner temperature of 90
The reaction was carried out at 0 ° C for 20 minutes. The reaction solution is allowed to cool, pH is adjusted to 6.5 with hydrochloric acid, and the precipitated crystals are collected by filtration to give 5-
667 mg of (2-aminomethyl) indanyl acetic acid was obtained as colorless crystals. Yield 76%. Melting point: 224 to 226 ° C MS (m / z): 205 (M + ) NMR (CD 3 OD) δ: 2.64 to 2.76 (m, 3H), 2.99 to 3.10 (m, 4)
H), 3.45 (s, 2H), 7.09 ~ 7.16 (m, 3H)

【0042】また、前記と同一の条件で反応を行い、反
応液を放冷した後、アンモニア水を溶出液としたイオン
交換樹脂(商品名:DIAION SK110)にて精製することに
よっても、5−(2−アミノメチル)インダニル酢酸6
80mgを無色結晶として得ることができた。収率77% 融点:220〜223℃
Also, by performing the reaction under the same conditions as above, allowing the reaction solution to cool, and purifying it with an ion exchange resin (trade name: DIAION SK110) using ammonia water as an eluent, 5- (2-Aminomethyl) indanyl acetic acid 6
80 mg could be obtained as colorless crystals. Yield 77% Melting point: 220-223 ° C

【0043】実施例2 5−{2−(4−クロロフェニル)スルホニルアミノメ
チル}インダニル酢酸ナトリウムの製造 参考例2で得た5−(2−カルバモイルメチル)インダ
ニル酢酸10.0gに、96%水酸化ナトリウム6.8
gを水80mlに溶かした水溶液を加えて溶解した。氷冷
下で12%次亜塩素酸ナトリウム29.3gを加え、同
温で10分間、次いで室温で50分間攪拌し、さらに1
5分間かけて内温90℃まで加熱し、内温90℃〜10
0℃で反応させた。反応液を氷冷した後、4−クロロベ
ンゼンスルホニルクロリド11.8gのトルエン13ml
溶液を加え、室温で20時間攪拌した。反応液に濃塩酸
8mlを加えてpH4に調整し、30分間攪拌した。析出
した粗結晶を吸引濾取し、水で洗浄した後、エタノール
−水混液から再結晶して、5−{2−(4−クロロフェ
ニル)スルホニルアミノメチル}インダニル酢酸13.
1gを無色結晶として得た。収率80%。 融点:180〜182℃ MS(m/z):379,381(M+) NMR(DMSO-d6)δ:2.47〜2.56(m,3H),2.76〜2.94
(m,4H),3.48(s,2H),6.96〜7.10(m,3H),7.66(d,2H),7.80
(d,2H),7.87(t,1H),12.20(brs,1H)
Example 2 Production of sodium 5- {2- (4-chlorophenyl) sulfonylaminomethyl} indanylacetate 10.0 g of 5- (2-carbamoylmethyl) indanylacetate obtained in Reference Example 2 was added with 96% hydroxylation. Sodium 6.8
An aqueous solution prepared by dissolving g in 80 ml of water was added and dissolved. Under ice-cooling, 12% sodium hypochlorite (29.3 g) was added, and the mixture was stirred at the same temperature for 10 minutes and then at room temperature for 50 minutes, and further 1
The internal temperature is heated to 90 ° C over 5 minutes, and the internal temperature is 90 ° C to 10 ° C.
The reaction was carried out at 0 ° C. The reaction mixture was ice-cooled, then 4-chlorobenzenesulfonyl chloride 11.8 g toluene 13 ml.
The solution was added and stirred at room temperature for 20 hours. The reaction solution was adjusted to pH 4 by adding 8 ml of concentrated hydrochloric acid and stirred for 30 minutes. The precipitated crude crystals were collected by suction filtration, washed with water, and then recrystallized from an ethanol-water mixture to give 5- {2- (4-chlorophenyl) sulfonylaminomethyl} indanyl acetic acid 13.
1 g was obtained as colorless crystals. Yield 80%. Melting point: 180 to 182 ° C MS (m / z): 379, 381 (M + ) NMR (DMSO-d 6 ) δ: 2.47 to 2.56 (m, 3H), 2.76 to 2.94
(m, 4H), 3.48 (s, 2H), 6.96-7.10 (m, 3H), 7.66 (d, 2H), 7.80
(d, 2H), 7.87 (t, 1H), 12.20 (brs, 1H)

【0044】5−{2−(4−クロロフェニル)スルホ
ニルアミノメチル}インダニル酢酸13.1gをメタノ
ール30mlに懸濁し、1N水酸化ナトリウム液28mlを
加えて加熱した。さらに炭酸水素ナトリウム600mgを
加熱下、少量づつ加えて溶解した。この溶液にヤシガラ
活性炭400mgを加え10分間加熱還流した後吸引濾過
し、母液を減圧濃縮した。得られた粗結晶を水から再結
晶した後24時間風乾し、5−{2−(4−クロロフェ
ニル)スルホニルアミノメチル}インダニル酢酸ナトリ
ウム・1水和物12.5gを無色結晶として得た。収率
86%。 融点:260℃(分解) NMR(DMSO-d6)δ:2.44〜2.52(m,3H),2.75〜2.89
(m,4H),3.16(s,2H),6.91〜7.01(m,3H),7.64(d,2H),7.80
(d,2H),8.13(brs,1H)
13.1 g of 5- {2- (4-chlorophenyl) sulfonylaminomethyl} indanyl acetic acid was suspended in 30 ml of methanol, and 28 ml of 1N sodium hydroxide solution was added to the suspension, followed by heating. Further, 600 mg of sodium hydrogen carbonate was added little by little under heating and dissolved. 400 mg of coconut husk activated carbon was added to this solution, heated under reflux for 10 minutes, and suction filtered, and the mother liquor was concentrated under reduced pressure. The obtained crude crystals were recrystallized from water and air dried for 24 hours to obtain 12.5 g of sodium 5- {2- (4-chlorophenyl) sulfonylaminomethyl} indanylacetate monohydrate as colorless crystals. Yield 86%. Melting point: 260 ° C. (decomposition) NMR (DMSO-d 6 ) δ: 2.44 to 2.52 (m, 3H), 2.75 to 2.89
(m, 4H), 3.16 (s, 2H), 6.91-7.01 (m, 3H), 7.64 (d, 2H), 7.80
(d, 2H), 8.13 (brs, 1H)

【0045】[0045]

【発明の効果】本発明の方法によると、強力なトロンボ
キサンA2拮抗剤などの製造中間体である置換インダン
誘導体(II)を、危険なアシルアジドのクルチウス転位
反応を行うことなく得ることができる。本発明の方法は
操作性がよく、高価な試薬を使うこともなく高収率・高
純度で製造を実施できるため、経済性、安全性に優れ、
工業的に有利な製法である。
INDUSTRIAL APPLICABILITY According to the method of the present invention, a substituted indane derivative (II) which is a production intermediate for a strong thromboxane A 2 antagonist or the like can be obtained without carrying out the dangerous Curtius rearrangement reaction of acyl azide. . The method of the present invention has good operability, and since it can be produced in high yield and high purity without using expensive reagents, it is excellent in economical efficiency and safety,
This is an industrially advantageous manufacturing method.

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 一般式(I) 【化1】 (式中、m、nはそれぞれ0〜3の数を示し、R1は水
素原子、低級アルキル基であり、R2は水素原子、酸素
原子である。)で表される化合物にホフマン転位反応を
行うことを特徴とする、一般式(II) 【化2】 (式中、m、n、R1、R2は前記と同意義である。)で
表される置換インダン誘導体の製造法。
1. A compound represented by the general formula (I): (In the formula, m and n each represent a number of 0 to 3, R 1 is a hydrogen atom or a lower alkyl group, and R 2 is a hydrogen atom or an oxygen atom.) To a compound represented by Hoffmann rearrangement reaction The general formula (II) is characterized in that (In the formula, m, n, R 1 and R 2 have the same meanings as described above.) A method for producing a substituted indane derivative.
JP15304394A 1994-06-13 1994-06-13 Production of substituted indan derivative Pending JPH07330697A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15304394A JPH07330697A (en) 1994-06-13 1994-06-13 Production of substituted indan derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15304394A JPH07330697A (en) 1994-06-13 1994-06-13 Production of substituted indan derivative

Publications (1)

Publication Number Publication Date
JPH07330697A true JPH07330697A (en) 1995-12-19

Family

ID=15553729

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15304394A Pending JPH07330697A (en) 1994-06-13 1994-06-13 Production of substituted indan derivative

Country Status (1)

Country Link
JP (1) JPH07330697A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106810460A (en) * 2016-12-30 2017-06-09 苏州诚和医药化学有限公司 A kind of preparation method of 4 [2 (dimethylamino) ethyoxyl] benzylamines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106810460A (en) * 2016-12-30 2017-06-09 苏州诚和医药化学有限公司 A kind of preparation method of 4 [2 (dimethylamino) ethyoxyl] benzylamines

Similar Documents

Publication Publication Date Title
JPS6317832B2 (en)
JPH05125051A (en) Synthesis of substituted (quinolin-2-yl- methoxy)phenyl acetic acid with uniform stereostructure
JPH02262558A (en) New method for producing phenyl-1-diethylaminocarbonyl- 1-phthalimidomethyl-2-cyclopropane z
JPS6324511B2 (en)
JP2000327603A (en) Production of propionic acid derivative
JPH07330697A (en) Production of substituted indan derivative
JP3647455B2 (en) Method for producing 3-isoxazolecarboxylic acid
JPH1087633A (en) Production of chiral succinic acid derivative
WO2000015596A1 (en) Processes for the preparation of fluorinated benzoic acids
JPH0841029A (en) 3-substituted quinoline-5-carboxylic acid derivative and itsproduction
JP2769058B2 (en) Preparation of cyclopropane derivatives
JP2003137835A (en) Method for producing (r)-3-hydroxy-3-(2-phenyl)hexanoic acid
US5508446A (en) Method for producing alkyl 3-phthalidylideneacetate
EP0454871B1 (en) Alpha, beta-unsaturated ketone and ketoxime derivative
JPH06340623A (en) Production of benzylsuccinic acid derivative and intermediate for its synthesis
JP3721540B2 (en) Pyrrolidine derivatives
KR100699457B1 (en) Process for preparing dibenzothiepin derivatives and intermediates thereof
JP2986003B2 (en) 2-Alkyl-3-styryloxiranecarboxylic acid ester and method for producing the same
JPH06336480A (en) Method for purifying intermediate for piperidine
JPS61246176A (en) Preparation of aminolactone
JPH0150219B2 (en)
JP2853929B2 (en) Method for producing 2-chloro-4,5-difluoro-3-methoxybenzoic acid
JPH0768194B2 (en) 5- (1-butyn-3-yl) oxy-4-chloro-2-fluoroacetanilide and process for producing the same
JPH0129793B2 (en)
JP3538889B2 (en) Method for producing alkylthioacetamide